Ted Murphy - 08 Jan 2022 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Jan 2022, 16:15:05 UTC
Next SEC filing
12 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Edward L. Murphy

Key filing fact

Ted Murphy filed Form 4 for Co-Diagnostics, Inc. (CODX) on 10 Jan 2022.

Key facts

  • This page summarizes Ted Murphy's Form 4 filing for Co-Diagnostics, Inc. (CODX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Jan 2022, 16:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CODX transaction

Common Stock

Award

Transaction value
$0
Shares
+12,500
Change %
+100%
Price
$0.000000
Shares after
25,000
Date
08 Jan 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CODX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-12,500
Change %
-50%
Price
$0.000000
Shares after
12,500
Date
08 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,000
Exercise price
$0.000000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .